2022. The role of miRNA200a as biomarker to detect breast and ovarian cancers in Iraqi women. Journal of Pharmaceutical Negative Results. 13, 4 (Oct. 2022), 463–467. DOI:https://doi.org/10.47750/pnr.2022.13.04.059.